Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors

Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors

Atherosclerosis is an underlying risk factor in cardiovascular diseases (CVDs). The combination of drugs with microRNAs (miRNA) inside a single nanocarrier has emerged as a promising anti-atherosclerosis strategy to achieve the exploitation of their complementary mechanisms of action to achieve syne...

Full description

Bibliographic Details
Main Authors: Baltazar Hiram Leal, Brenda Velasco, Adriana Cambón, Alberto Pardo, Javier Fernandez-Vega, Lilia Arellano, Abeer Al-Modlej, Víctor X. Mosquera, Alberto Bouzas, Gerardo Prieto, Silvia Barbosa, Pablo Taboada
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pharmaceutics
Subjects:
nanoparticles
combination therapy
atherosclerosis
miRNA
statin
inflammation
Online Access:https://www.mdpi.com/1999-4923/14/2/258

Similar Items

Similar Items